Zhengye Biotechnology Holding (ZYBT) Enterprise Value (2023 - 2025)

Zhengye Biotechnology Holding (ZYBT) has 3 years of Enterprise Value data on file, last reported at $712717.6 in Q4 2025.

• Enterprise Value for Q4 2025 came in at $712717.6, down 89.45% year-over-year; the trailing twelve-month figure through Dec 2025 was $712717.6 (down 89.45% YoY), and the FY2025 annual result was $922212.1, down 86.11% from the prior year.
• Enterprise Value declined to $712717.6 in Q4 2025 per ZYBT's latest filing, from $6.4 million in the prior quarter.
• Over five years, Enterprise Value peaked at $6.8 million in Q4 2024 and troughed at $712717.6 in Q4 2025.
• A 3-year average of $4.8 million and a median of $5.8 million in 2023 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value gained 28.0% in 2024, then slumped 89.45% in 2025.
• A 3-year view of Enterprise Value shows it stood at $5.3 million in 2023, then advanced by 28.0% to $6.8 million in 2024, then tumbled by 89.45% to $712717.6 in 2025.
• Business Quant data shows ZYBT's Enterprise Value at $712717.6 in Q4 2025, $6.4 million in Q2 2025, and $6.8 million in Q4 2024.